Recently MS covered a play on the leveraged ETF known as LABD. After pulling 30%+ gains, the team has exited and begun eyeing a new opportunity in the same space. M&A optimism and high … [Read more...] about Biotech Bull Move
Swing Trades
Why I’m Bullish On Brexit: Part deux
As the Market's overheating, (Nasdaq: LABD) the S&P Biotech Bear 3x hits all-time lows, and Brexit fears loom. LABD gives a nice potential entry for biotech traders looking for protection the next … [Read more...] about Why I’m Bullish On Brexit: Part deux
MS Swing Move #Focused
Nasdaq: EYPT) Eyepoint Pharmaceuticals #focus by follow_the_money on TradingView.com This past week Eyepoint Pharmaceuticals filed form 4's three days in a row. Interestingly, this week Eyepoint … [Read more...] about MS Swing Move #Focused
ADMA Presents Potential Entry For Investors On The Sideline
Today Adma Biologics (Nasdaq: ADMA) sold off ~10% closing at $3.50. Most of us already in Adma were not phased. Personally, I saw this as a healthy pullback. Since February 1st ADMA has gained 25% … [Read more...] about ADMA Presents Potential Entry For Investors On The Sideline
Buying The Panic
For this move, we are buying the panic. Insys Therapeutics (Nasdaq: INSY) has dropped significantly in the past few weeks. The downtrend started following INSY's fourth-quarter 2018 earnings … [Read more...] about Buying The Panic
(Nasdaq: GALT) Galectin Therapeutics, Reversal?
According to Elliot wave theory and Fibonacci ratio, GALT is showing bullish signs of reversal. GALT ran up from $3.19 to $6.06. It has since pulled back to ~$4.19 (also, .786 retracement) #KEY … [Read more...] about (Nasdaq: GALT) Galectin Therapeutics, Reversal?
More Near-Term Downside For KPTI
KPTI's data does not adequately demonstrate a treatment benefit from Oral Selinexor plus low-dose dexamethasone in Penta-Relapsed/Refractory Multiple Myeloma (RRMM).Serious adverse events during … [Read more...] about More Near-Term Downside For KPTI
Technically Swinging CNAT
Swing Thesis This swing-trade for Conatus Pharmaceuticals, (Nasdaq: CNAT) is based on Technical Analysis (which aligns with some key dates) and a fundamental component. With regards to technical … [Read more...] about Technically Swinging CNAT
$REPH – Recro Pharma, PDUFA Swing Trade
Introduction Recro Pharma (NASDAQ: REPH) engages in the research and development of non-opioid therapeutics for the treatment of acute postoperative pain. REPH is currently developing three … [Read more...] about $REPH – Recro Pharma, PDUFA Swing Trade
MS Identified Its Next Swing
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Preface WOW. We are absolutely elated with the performance of our last swing move on SCYX. In case you missed it on … [Read more...] about MS Identified Its Next Swing
